ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 30 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $2,673,000 | -17.7% | 1,691,857 | 0.0% | 0.10% | -18.6% |
Q3 2014 | $3,248,000 | -43.4% | 1,691,857 | 0.0% | 0.12% | -48.9% |
Q2 2014 | $5,735,000 | +1.2% | 1,691,857 | 0.0% | 0.23% | 0.0% |
Q1 2014 | $5,668,000 | +9.1% | 1,691,857 | 0.0% | 0.23% | -14.1% |
Q4 2013 | $5,194,000 | -23.6% | 1,691,857 | 0.0% | 0.27% | -14.9% |
Q3 2013 | $6,801,000 | – | 1,691,857 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 3,056,196 | $11,063,000 | 4.05% |
ProQuest Associates IV LLC | 1,900,000 | $6,878,000 | 2.67% |
Abingworth LLP | 437,994 | $1,577,000 | 1.46% |
Hilltop Park Associates LLC | 65,000 | $235,000 | 0.52% |
Hilltop Park Associates LLC | 65,000 | $234,000 | 0.52% |
Perceptive Advisors | 1,492,156 | $5,402,000 | 0.47% |
Broadfin Capital, LLC | 1,154,674 | $4,180,000 | 0.40% |
Rhenman & Partners Asset Management AB | 435,000 | $1,575,000 | 0.31% |
Rock Springs Capital Management LP | 450,000 | $1,629,000 | 0.14% |
Gruss Capital Management LP | 706,000 | $2,556,000 | 0.08% |